WEREWOLF THERAPEUTICS, INC.
Cash Flow Statement
| Line Item | Jun 2026 | Mar 2026 | Sep 2025 | Jun 2025 | Mar 2025 | Sep 2024 | Jun 2024 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $3.7M | $-13.5M | $-16.4M | $-18.0M | $-18.1M | $-16.7M | $-17.2M | $-16.2M |
| Depreciation & Amortization | — | — | — | — | — | — | — | — |
| Depreciation | — | $398.0K | — | — | $426.0K | — | — | $464.0K |
| Amortization | — | — | — | — | — | — | — | — |
| Stock-Based Compensation | — | $929.0K | — | — | $2.0M | — | — | $2.3M |
| Net Cash from Operating Activities | $6.6M | $-10.6M | $-15.2M | $-15.2M | $-18.9M | $-12.5M | $-14.2M | $-15.3M |
| Investing Activities | ||||||||
| Capital Expenditures | — | — | $0 | $0 | $0 | $3.0K | $17.0K | $111.0K |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | — | — | — | — | $0 | — | — | $-111.0K |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | — | — | — | — | $0 | — | — | $20.3M |
| Net Change in Cash | — | $-10.6M | — | — | $-18.9M | — | — | $4.9M |
| Free Cash Flow | — | — | $-15.2M | $-15.2M | $-18.9M | $-12.5M | $-14.2M | $-15.4M |